Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatih Celik

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Applied Oral Science : Revista FOB|March 26, 2025
Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in ratsIsmail Salcan, Muhammed Dilber, Zeynep Suleyman, et al.
BMC Complementary Medicine and Therapies|December 12, 2025
The effect of Hippophae rhamnoides on Hydroxychloroquine-Induced stomatitis in ratsMuhammet Dilber, Zeynep Suleyman, Nurinisa Yucel, et al.
International Ophthalmology|May 27, 2022
Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's diseaseFatih Celik, Ebru Coteli, Fatih Cem Gul, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Applied Oral Science : Revista FOB|March 26, 2025
Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in ratsIsmail Salcan, Muhammed Dilber, Zeynep Suleyman, et al.
BMC Complementary Medicine and Therapies|December 12, 2025
The effect of Hippophae rhamnoides on Hydroxychloroquine-Induced stomatitis in ratsMuhammet Dilber, Zeynep Suleyman, Nurinisa Yucel, et al.
International Ophthalmology|May 27, 2022
Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's diseaseFatih Celik, Ebru Coteli, Fatih Cem Gul, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Pageof 5